Tasmar / Tolcapone

Modified on 2009/10/14 21:41 by admin
Tasmar, also known as tolcapone, is a C.O.M.T. inhibitor and is used to treat symptoms associated with Parkinson's disease. The drug is manufactured by Roche Pharmaceuticals. Tasmar is often used in combination with other Parkinson medications such as levodopa and carbidopa.

In 1998 Roche issued a warning letter to doctors informing them of the increased risk of liver problems in patients taking Tasmar. The letter suggests that doctors only give Tasmar to those patients who do not respond to other similar medications. The drug has caused fatal liver failure in at least three people. The more than 60,000 people who have taken Tasmar may be 100 times more likely to develop liver problems than those who have not taken the drug. Roche refers to the liver damage caused by Tasmar as a "hepatocellular injury."

See your doctor if you have experienced serious side effects associated with Tasmar. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Parkinson's Disease Drugs: Overview
  2. Liver Problems
  Name Size